Trial Profile
Keishibukuryogan (Japanese Herbal Supplement) for the Adjunctive Treatment of Catamenial Epilepsy in Adult: Safety Study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs TJ 25 (Primary)
- Indications Catamenial seizures
- Focus Adverse reactions; Therapeutic Use
- 25 Feb 2011 New trial record